Freshly Printed - allow 7 days lead
Couldn't load pickup availability
Hemovigilance
An Effective Tool for Improving Transfusion Safety
René R. P. De Vries (Edited by), R P De Vries (Author), Jean-Claude Faber (Edited by)
9780470655276, Wiley
Hardback, published 31 August 2012
400 pages
25.4 x 19.3 x 2.3 cm, 1.002 kg
“This is a thoroughly fascinating read and will make you eager to implement or enhance your current hemovigilance efforts. I recommend it.” (Doody’s, 26 April 2013)
* Hemovigilance is a "quality process" which aims to improve quality and increase safety of blood transfusion, by surveying all activities of the blood transfusion chain, from donors to recipients. Hemovigilance programmes have now been in existence for over 15 years, but many countries and centers are still at the development stage. This valuable resource brings together the main elements of such programmes and shows the different types of models available. A general introduction includes Chapters on hemovigilance as a quality tool for transfusion as well as concepts of and models for hemovigilance. The core of the book describes how Hemovigilance systems have been set up and how they work in hospitals, blood establishments, and at a national level. These Chapters are written according to a structured template: products and processes, documentation of jobs, monitoring and assessment, implementation and evaluation of measures for improvement, education and training. Chapters on Hemovigilance at the International level, Achievements and new developments complete the picture. Hemovigilance is above all a practical guide to setting up and improving hemovigilance systems, whilst raising awareness for reporting adverse events and reactions. This is the first international book on hemovigilance, assembling all the vital issues in one definitive reference source - essential reading for all staff involved in the transfusion process.
List of Contributors, viii Foreword, xii Part 1 General Introduction 1 Introduction, 3 2 Hemovigilance: A Quality Tool for the Blood Transfusion Chain, 5 3 Concepts and Models, 12 Part 2 Hemovigilance of the Blood Transfusion Chain (Blood Establishment and Hospital) 4 Setting Up or Consolidating a System for Donor Hemovigilance at the Level of a Blood Establishment, 21 5 Preparation of Blood Components, 36 6 Establishment of Hemovigilance for the Testing, Storage, Distribution, Transport, and Issuing of Blood and Blood Components: The Example of Greece, 52 7 Medical Decision, Ordering, Administration of Component, and Monitoring of the Patient, 61 8 Blood Donation: An Approach to Donor Vigilance, 77 9 Preparation of Blood Components, 99 10 Testing, Issuing, and Transport of Blood Components, 113 11 Clinical Activities: Medical Decision-making, Sampling, Ordering Components, Administration, and Patient Monitoring, 126 Part 3 National or Regional Hemovigilance Systems 12 The French Hemovigilance Network: From the Blood Scandal to Epidemiologic Surveillance of the Transfusion Chain, 147 13 The Japanese Hemovigilance System, 159 14 Setting up a National Hemovigilance System: SHOT, 168 15 The Dutch Hemovigilance System: Transfusion Reactions in Patients (TRIP), 180 16 Regulatory, Public Health, and International Aspects of Hemovigilance in Canada, 191 17 Setting up and Implementation of the National Hemovigilance System in Italy, 204 18 The Australian Hemovigilance System, 209 19 Biovigilance in the United States, 220 20 Arab Hemovigilance Network, 226 Part 4 Hemovigilance at the International Level 21 Hemovigilance in the European Community, 235 22 International collaboration, 253 23 Hemovigilance in Developing Countries, 260 Part 5 Achievements 24 Achievements Through Hemovigilance, 281 Part 6 Developments 25 Vigilance of Alternatives for Blood Components, 305 26 Surveillance of Clinical Effectiveness of Transfusion, 322 27 Biovigilance, 326 Appendices Appendix A Glossary, 343 Appendix B Proposed standard definitions for surveillance of non infectious adverse transfusion reactions, 351 Appendix C Standard for surveillance of complications related to blood donation, 360 Index, 369
RenéR.P.deVries
RenéR.P.deVries
René R.P. de Vries and Jean-Claude Faber
Section 2.1: Setting up a Hemovigilance System
Johanna Wiersum-Osselton, Wim de Kort, Tanneke Marijt-van der Kreek, and Jeroen de Wit
Tomislav Vuk
Constantina Politis
Mickey B.C. Koh, Ramir Alcantara, Mark Grumbridge, and Ai Leen Ang Section 2.2: How the System Works
Peter Tomasulo, Madhav Erraguntla, and Hany Kamel
Erhard Seifried, Reinhard Henschler, Juergen Luhm, Thea Mueller-Kuller, Hans-Ulrich Pfeiffer, Walid Sireis, and Markus M. Mueller
Constantina Politis
Clare Taylor
Philippe Renaudier
Hitoshi Okazaki, Naoko Goto, Shun-ya Momose, Satoru Hino, and Kenji Tadokoro
Hannah Cohen and Lorna M. Williamson
Martin R. Schipperus, Johanna Wiersum-Osselton, Pauline Y. Zijlker-Jansen, and Anita J.W. van Tilborgh-de Jong
Peter R. Ganz and Jun Wu
Giuliano Grazzini and Simonetta Pupella
Erica M. Wood, Lisa J. Stevenson, Simon A. Brown, and Christopher J. Hogan
D. Michael Strong, Barbee Whitaker, Matthew J. Kuehnert, and Jerry A. Holmberg
Salwa Hindawi, Magdy Elekiaby, and Gamal Gabra
Jean-Claude Faber
Paul F.W. Strengers
Jean-Claude Faber
Jean-Claude Faber and Fátima Nascimento
Dafydd Thomas
Brian McClelland and Katherine Forrester
Jerry A. Holmberg, Matthew J. Kuehnert, and D. Michael Strong
Subject Areas: Clinical & internal medicine [MJ]
